Delivery Order SPE2DB24D2205-SPE2DB24FDXTX
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
The U.S. Defense Logistics Agency (DLA) awarded a $9,954.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.51, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract was awarded on May 23, 2024 and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pen, with a ceiling value of $14,872.96 and a completion date of July 10, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a Set-Aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 12.5 mg/0.5 mL pens. The contract, valued at $1,578.00, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price pricing type. The contract has an ultimate completion date of November 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The award, valued at $10,221.48, is a delivery order under an Indefinite Delivery Contract (IDC) with a total potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,035.35, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a ceiling value of $20,165.02 and a period of performance through October 26, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Mounjaro (tirzepatide) 15 mg/0.5 ml pen. The $3,897.84 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military healthcare programs....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The award, valued at $1,578, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...